Bluebird Bio Shares Down 10%; Cantor Downgrades Stock To Sell
Cantor Fitzgerald wasn’t impressed by bluebird bio inc BLUE 1.92%’s investor day event on Thursday. Analyst Elemer Piros downgraded the stock to Sell following the event and doesn’t expect any new data from the company at the upcoming ASH conference in December.